Daunomycinone
CAS : 21794-55-8
Ref. 3D-FD20803
5mg | 146,00 € | ||
10mg | 202,00 € | ||
25mg | 364,00 € | ||
50mg | 485,00 € | ||
100mg | 715,00 € |
Informations sur le produit
- (8S,10S)-8-Acetyl-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-methoxy- -5,12-naphthacenedione(+)-DaunomycinoneDaunomycin aglicone DaunorubicinoneEpirubicin Impurity B
- (+)-Daunomycinone
- (8S,10S)-8-Acetyl-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-methoxy-5,12-naphthacenedione
- 5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-methoxy-, (8S-cis)-
- 5,12-naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-methoxy-, (8S,10S)-
- Daunomycin aglicone
- Daunomycinon
- Daunomycinone derivative
- Daunorubicin aglycone
- Daunorubicinone
- Voir d'autres synonymes
- Leukaemomycinone C
- NSC 109351
Daunomycinone is a chemical compound that belongs to the group of antitumor agents. It is used in cancer therapy and has been shown to inhibit protein synthesis, leading to cell death. Daunomycinone can be synthesized by reacting adriamycin with trifluoroacetic acid in the presence of an organic base. This reaction produces a daunomycinone molecule that has a hydroxyl group at one end and a carbonyl group at the other. The binding constants between daunomycinone and human serum proteins have been determined experimentally using molecular modeling techniques. Hydrogen bonding interactions are also present in this complex, which may account for its high affinity for proteins found in human serum.
Propriétés chimiques
Question d’ordre technique sur : 3D-FD20803 Daunomycinone
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages